CA00288U1066
CA00288U1066
AbCellera Biologics Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 75.128.000 | 28.833.000 | 160.6% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | 28.833.000 | -- |
| 278.341.000 | 329.979.000 | 15.6% | |
| Operating Income | -203.213.000 | -301.146.000 | 32.5% |
| Pretax Income | -177.595.000 | -200.395.000 | 11.4% |
| Net Income Common Stockholders | -146.412.000 | -162.857.000 | 10.1% |
| -- | -- | -- | |
| -- | -- | -- |